Skip to content
Relatix Health

Relatix Health

Radically different

  • Participate
    • Start here
  • Services
    • Tests to participate in
  • Resources
  • About
    • Our Vision – A radically different future
    • Our mission – personalised lifelong support
    • News
    • FAQ
    • Contact
    • Trust and Privacy
    • Support us
  • Log in / Sign up
Posted on June 24, 2026 by admin

Pramipexole vs Placebo Treatment in Bipolar Disorder With Anhedonic Depression

Conditions: Bipolar Disorder (BD)

Interventions: Drug: Pramipexole

Sponsors: Daniel Lindqvist

Not yet recruiting
CategoriesClinicalTrials.gov TagsBipolar, Depression, Mood and emotional regulation, Sexual drive and regulation

Post navigation

Previous PostPrevious Effectiveness of Neuroplasticity-Targeted Supplements on Neuroinflammatory Markers, ADHD Symptom Severity, and Clinical Scores in Children
Next PostNext Risperidone vs Cariprazine in Acute Mania
Relatix Health

Relatix Health helps people understand their minds, explore relevant support and take part in research on their own terms. We connect lived experience with responsible research while protecting privacy, dignity and choice.

For researchers, clinicians and organisations, visit our sister site, Relatix Bio.

Take part

Start here Participate Tests to participate in Log in or sign up

Find support

Resources Services FAQ I need help now

Our commitments

Our Vision Our Mission Trust and Privacy

About

About us News Support us Contact

© 2026 Relatix Health. All rights reserved.